Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | HUT | IBRX |
|---|---|---|
| Price | $89.27 | $10.38 |
| Change today | ▼ 0.40% | ▲ 0.92% |
| Market cap | $11.00B | $11.00B |
| Return, 3 months | -7.7% | +18.5% |
| Return, year to date | +94.3% | +424.2% |
| Return, 1 year | +115.5% | +310.3% |
| P/E (TTM) | -16.6 | -10.9 |
| P/B | 7.6 | -10.5 |
| P/E percentile vs own 5y | – | – |
| Dividend yield | – | – |
| Revenue growth (YoY, latest qtr) | – | – |
| Net profit growth (YoY) | – | – |
| Gross margin | – | – |
| Operating margin | – | – |
| Net margin | – | – |
| Return on equity | – | – |
| Analyst target vs. price | – | – |
| Analyst buy share | – | – |
| RSI (14) | 47 | 71 |
| 30-day volatility | 80.8% | 67.6% |
| Max drawdown, 1 year | -41.7% | -42.3% |
| Trend read | Leaning bearish | Strong uptrend |
| Analyst consensus | – | – |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
